MedPath

CHRONOtype-adjusted DIET on Weight Loss

Not Applicable
Completed
Conditions
Obesity
Interventions
Procedure: CHRONOTYPE-ADJUSTED DIET
Registration Number
NCT03755674
Lead Sponsor
Universidad Católica San Antonio de Murcia
Brief Summary

BACKGROUND: Several reports have observed that the alteration of normal biological rhythms is associated with obesity development. In this regard, those subject with the preference for evening seems to be prone to develop obesity. However, the current treatment of obesity does not take into account these aspects OBJECTIVE: To evaluate whether a diet adjusted to patient's chronotype is more effective than the current dietary recommendations.

SUBJECTS/METHODS: 209 subjects take part in a randomized, double-blind clinical trial. 104 subjects followed a typical hypocaloric dietary treatment (CONTROL) and the other 105 subjects undergone a diet with a daily caloric distribution adjusted to their chronotype (CHRONO).

CONCLUSIONS: A chronotype-adjusted diet may be a promising alternative to the classical hypocaloric dietary treatment since the investigator's data indicate a higher effectiveness regarding weight loss when the diet was adjusted to the patient's chronotype.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria
  • students or staff of the Catholic University of Murcia (UCAM), with an age ranged between 18 and 65 years old
Exclusion Criteria
  • clinically significant illnesses (including type 2 diabetes, chronic heart failure, hepatitis and cancer)
  • those taking any medications known to affect body weight (thyroid hormones, corticosteroids, etc.)
  • women in special physiological situations (pregnant, lactating).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CHRONOTYPE-ADJUSTED DIETCHRONOTYPE-ADJUSTED DIETPatients that undergo a chronotype adjusted diet
Primary Outcome Measures
NameTimeMethod
Total weight loss, in percentage, from baseline to end-of-treatment12 weeks

Percentage of weight loss, measured with a scale, from baseline weight (100% body weight) since body weight after 12 weeks of treatment (final body weight). Percentage of body weight was then measured as Total Weight Loss (%) = (Final body weight - Baseline body weight) / baseline body weight x 100.

Secondary Outcome Measures
NameTimeMethod
Anthropometrical and other clinical parameters12 weeks

Improvement of anthropometrical and other clinical parameters during the treatment

BMI loss12 weeks

BMI decrease from baseline

© Copyright 2025. All Rights Reserved by MedPath